Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Uterine sarcomas: a clinicopathologic study.

S Chiara1, G Foglia, F Odicino

  • 1Istituto Nazionale per la Ricerca sul Cancro di Genova, Italia.

Oncology
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Omics sciences and precision medicine in lung cancer.

La Clinica terapeutica·2023
Same author

Omics sciences and precision medicine in colon cancer.

La Clinica terapeutica·2023
Same author

Omics sciences and precision medicine in sarcoma.

La Clinica terapeutica·2023
Same author

Omics sciences and precision medicine in glioblastoma.

La Clinica terapeutica·2023
Same author

Omics sciences and precision medicine in prostate cancer.

La Clinica terapeutica·2023
Same author

Omics sciences and precision medicine in breast and ovarian cancer.

La Clinica terapeutica·2023
Same journal

SF3A3 in Liver Hepatocellular Carcinoma: Oncogenic Role and Prognostic Significance.

Oncology·2026
Same journal

Letter to the Editor.

Oncology·2026
Same journal

FLAG-Based Versus Standard 7+3 Induction Therapy in Adults with Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis.

Oncology·2026
Same journal

Longitudinal Changes in Body Weight and Body Mass Index in Patients with Chronic-Phase Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors: A Retrospective Observational Study.

Oncology·2026
Same journal

Rising lung cancer burden attributable to high fasting plasma glucose in women aged ≥50 years: age-, SDI-, and BRICS-specific patterns from GBD 1990-2021.

Oncology·2026
Same journal

Diagnostic Pathways and Outcomes of First-Line Atezolizumab plus Bevacizumab in Patients with Locoregional Therapy-Ineligible Hepatocellular Carcinoma at Initial Diagnosis.

Oncology·2026
See all related articles

This study on uterine sarcoma found that pathological stage is a key prognostic factor. Early-stage uterine sarcoma patients had better survival rates than those with advanced disease.

Area of Science:

  • Gynecologic Oncology
  • Pathology
  • Surgical Oncology

Background:

  • Uterine sarcoma diagnosis relies on histologic criteria, but prognostic factors require further elucidation.
  • Understanding prognostic indicators is crucial for tailoring treatment and improving patient outcomes in uterine sarcoma.

Purpose of the Study:

  • To evaluate the validity of histologic criteria for uterine sarcoma.
  • To examine the influence of prognostic factors and treatment on survival in uterine sarcoma patients.

Main Methods:

  • Retrospective review of 48 initial uterine sarcoma cases, with 32 included after pathologic review.
  • Analysis of surgical pathological staging, histological type, patient age, menopausal status, and treatment modalities.

Main Results:

Related Experiment Videos

  • The 5-year overall survival rate for the studied uterine sarcoma cohort was 13.1%.
  • FIGO stage was a significant prognostic factor: 33.5% survival for Stage I-II vs. 0% for Stage III-IV.
  • Heterologous elements and lymphovascular invasion impacted prognosis in mixed mesodermal tumors; adjuvant therapy showed a trend towards improved survival.

Conclusions:

  • Surgical pathological staging is a critical determinant of survival in uterine sarcoma.
  • Histological type, age, and menopausal status did not significantly affect survival.
  • Adjuvant therapy may offer survival benefits, warranting further investigation in uterine sarcoma management.